Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2023
Programm
Suche
DE
Alle Personen
David García Azorín
Sortiert nach Typ
Datum
Vorsitz
07.12.2023
09:45
–
10:45
Teaching course
TC 1 | Secondary headaches
Breakout room 2
Invited speaker
Invited lecture
Clinical pearls, mimics and chameleons of secondary headache disorders
Vortrag
Abstract lecture
AL004
Migraine impact on patient's life in terms quality of life and mental health (2020 national health and wellness survey)
ePoster
P127
Cost and burden of migraine: impact in work productivity and healthcare resource utilization in Spain
ePoster
P130
EndoCEF: Frequency of headache and associated factors in patients with left-sided infective endocarditis
ePoster
P093
Mimics and chameleons of headache attributed to
Influenza
infection: a prospective cohort study
ePoster
P024
Three-and-six month effectiveness of CandeSpartan in the treatment of migraine: the CandeSpartan study (NCT: 04138316)
ePoster
P192
Epidemiology, disability and treatment satisfaction of physician-diagnosed migraine respondents using the National health and wellness survey in Spain
ePoster
P230
Observational prospective study on the presence of typical migraine features in nummular headache patients: The Numamig study (NCT04299958)
Abstract lecture
AL017
MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients
Weitere Beteiligungen
Abstract lecture
AL004
Migraine impact on patient's life in terms quality of life and mental health (2020 national health and wellness survey)
ePoster
P055
Galcanezumab for migraine prevention in patients above 65: a multicenter study in real-world settings
ePoster
P127
Cost and burden of migraine: impact in work productivity and healthcare resource utilization in Spain
ePoster
P058
Evaluation of the accuracy of the predictive algorithm of response to anti-CGRP monoclonal antibodies in patients with migraine older than 65 years: external validation study
ePoster
P021
Predictors of ≥50% and ≥75% response to anti-CGRP monoclonal antibodies for migraine prevention in real life: results from a european multicenter observational study including 5818 patients
ePoster
P128
Neuroimaging findings in persistent headache after Covid-19. Related or incidental?
ePoster
P130
EndoCEF: Frequency of headache and associated factors in patients with left-sided infective endocarditis
ePoster
P061
Evaluation of the concomitant use of preventive treatments in patients with migraine under anti-CGRP therapies: the PREVENAC study
ePoster
P093
Mimics and chameleons of headache attributed to
Influenza
infection: a prospective cohort study
ePoster
P024
Three-and-six month effectiveness of CandeSpartan in the treatment of migraine: the CandeSpartan study (NCT: 04138316)
ePoster
P138
Relationship between migraine attacks per month and the resting-state brain functional network
ePoster
P192
Epidemiology, disability and treatment satisfaction of physician-diagnosed migraine respondents using the National health and wellness survey in Spain
ePoster
P230
Observational prospective study on the presence of typical migraine features in nummular headache patients: The Numamig study (NCT04299958)
ePoster
P206
Medium-term gray matter structural longitudinal changes in patients with persistent headache after COVID-19
ePoster
P296
External validation of the predictive model of response to anti-CGRP monoclonal antibodies in patients with migraine
ePoster
P198
Long-term evolution of white matter structural changes in migraine patients
Abstract lecture
AL013
RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine
Abstract lecture
AL017
MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients
v1.21.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz